Vytrus Biotech, S.A. (BME:VYT)
Spain flag Spain · Delayed Price · Currency is EUR
19.50
-0.25 (-1.27%)
At close: Apr 28, 2026

Vytrus Biotech Revenue

In the year 2025, Vytrus Biotech had annual revenue of 9.69M EUR with 59.15% growth. Vytrus Biotech had revenue of 3.06M in the half year ending December 31, 2024, with 46.56% growth.

Revenue
9.69M
Revenue Growth
+59.15%
P/S Ratio
15.12
Revenue / Employee
220.28K
Employees
44
Market Cap
146.57M

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 20259.69M3.60M59.15%
Dec 31, 20246.09M1.39M29.51%
Dec 31, 20234.70M219.70K4.90%
Dec 31, 20224.48M968.83K27.57%
Dec 31, 20213.51M1.28M57.47%
Dec 31, 2020 Pro Pro Pro
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Grifols 7.52B
Laboratorios Farmaceuticos Rovi 743.48M
Almirall 1.11B
Pharma Mar 221.39M
Clínica Baviera 304.91M
Prim, S.A. 251.89M
Atrys Health 144.31M
Laboratorio Reig Jofre 336.68M
Revenue Rankings